SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-175245
Filing Date
2018-05-25
Accepted
2018-05-25 16:01:56
Documents
8
Period of Report
2018-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d581312d8k.htm 8-K 25252
2 EX-1.1 d581312dex11.htm EX-1.1 184549
3 EX-5.1 d581312dex51.htm EX-5.1 6611
4 EX-99.1 d581312dex991.htm EX-99.1 9105
5 EX-99.2 d581312dex992.htm EX-99.2 9244
6 GRAPHIC g581312g08d68.gif GRAPHIC 2049
7 GRAPHIC g581312g54t06.gif GRAPHIC 7441
8 GRAPHIC g581312g73w48.gif GRAPHIC 4720
  Complete submission text file 0001193125-18-175245.txt   256097
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 18861511
SIC: 2836 Biological Products, (No Diagnostic Substances)